School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada; ICES, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
J Am Med Dir Assoc. 2022 Jun;23(6):936-941. doi: 10.1016/j.jamda.2022.02.011. Epub 2022 Feb 28.
To examine the association between the COVID-19 pandemic and opioid use among nursing home residents followed up to March 2021, and possible variation by dementia and frailty status.
Population-based cohort study with an interrupted time series analysis.
Linked health administrative databases for residents of all nursing homes (n = 630) in Ontario, Canada were examined. Residents were divided into consecutive weekly cohorts (first observation week was March 5 to 11, 2017 and last was March 21 to March 27, 2021).
The weekly proportion of residents dispensed an opioid was examined overall and by strata defined by the presence of dementia and frailty. Autoregressive Integrated Moving Average models with step and ramp intervention functions tested for immediate level and slope changes in weekly opioid use after the onset of the pandemic (March 1, 2020) and were fit on prepandemic data for projected trends.
The average weekly cohort ranged from 76,834 residents (prepandemic) to 69,359 (pandemic period), with a consistent distribution by sex (69% female) and age (54% age 85 + years). There was a statistically significant increased slope change in the weekly proportion of residents dispensed opioids (parameter estimate (β) = 0.035; standard error (SE) = 0.005, P < .001). Although significant for all 4 strata, the increased slope change was more pronounced among nonfrail residents (β = 0.038; SE = 0.008, P < .001) and those without dementia (β = 0.044; SE = 0.008, P < .001). The absolute difference in observed vs predicted opioid use in the last week of the pandemic period ranged from 1.25% (frail residents) to 2.28% (residents without dementia).
Among Ontario nursing home residents, there was a statistically significant increase in opioid dispensations following the onset of the pandemic that persisted up to 1 year later. Investigations of the reasons for increased use, potential for long-term use and associated health consequences for residents are warranted.
研究 2021 年 3 月之前,随着新冠肺炎疫情的爆发,养老院居民的阿片类药物使用情况及其与痴呆和衰弱状况的关系。
基于人群的队列研究,采用中断时间序列分析。
对加拿大安大略省所有养老院(n=630)的居民进行了链接健康管理数据库的调查。居民被分为连续的每周队列(第一观察周为 2017 年 3 月 5 日至 11 日,最后一周为 2021 年 3 月 21 日至 27 日)。
总体上和按照痴呆和衰弱的有无进行分层,观察每个队列中每周开具阿片类药物的居民比例。在疫情爆发后(2020 年 3 月 1 日),采用自回归综合移动平均模型(带有阶跃和斜坡干预函数)检验阿片类药物每周使用量的即时水平和斜率变化,并根据疫情前的数据拟合预测趋势。
每周平均队列规模从疫情前的 76834 名居民(76834 名)到疫情期间的 69359 名(69359 名),男女比例(69%为女性)和年龄(54%年龄在 85 岁以上)分布均匀。每周开具阿片类药物的居民比例呈显著的斜率变化(参数估计值(β)=0.035;标准误差(SE)=0.005,P<0.001)。虽然在所有 4 个分层中均有显著意义,但在非虚弱居民(β=0.038;SE=0.008,P<0.001)和无痴呆居民(β=0.044;SE=0.008,P<0.001)中斜率变化更为显著。在疫情最后一周,观察到的与预测的阿片类药物使用之间的绝对差异范围从 1.25%(虚弱居民)到 2.28%(无痴呆居民)。
在安大略省养老院居民中,疫情爆发后阿片类药物的使用呈显著上升趋势,且持续了 1 年以上。需要调查居民增加使用的原因、潜在的长期使用情况以及对居民健康的相关影响。